The finding that within the intestinal epithelia normal function of Mbd2 is required to permit tumourigenesis is supported by clinical data; CRC sequencing data and a small study looking specifically at MBD2 status42 indicate that loss of MBD2 is a rare event in CRC patients43, 44. This evidence concerns the gene MBD2 and colorectal carcinoma.